Commission’s Chief Scientific Advisors publish statement on the regulation of gene editing
On 13 November 2018, the European Commission’s Scientific Advice Mechanism (SAM) Group of Chief Scientific Advisors published a statement providing ‘a scientific perspective on the regulatory status of products derived from gene editing, and the implications for the GMO Directive’.
This follows the Court of Justice of the European Union’s judgement of 25 July 2018 that organisms obtained using new techniques of directed mutagenesis (including those popularly known as ‘gene editing techniques’) are genetically modified organisms (GMOs) and are subject to the obligations of the corresponding legislation (Directive 2001/18/EC, the ‘GMO Directive’).
The advisors conclude that the GMO Directive should be revised to reflect current knowledge and scientific evidence, and as part of a broad dialogue with relevant stakeholders and the public at large.
The statement can be downloaded here.